This inventor holds 1 USPTO granted patent. Top assignees: Ludwig Institute for Cancer Research Limited, Orion Corporation. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 530 
1 out of 190 
Years Active: 2000
Title: Marja-Terttu Matikainien: Innovator in Antibody Research
Introduction
Marja-Terttu Matikainien is a notable inventor based in Mynamaki, Finland. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting receptor tyrosine kinases.
Latest Patents
Matikainien holds a patent for "Antibodies to Flt4, a receptor tyrosine kinase and uses thereof." This invention provides purified Flt4 receptor tyrosine kinase polypeptides and fragments, along with polynucleotides encoding such polypeptides and antibodies that specifically bind to them. The applications of this invention are crucial for advancing therapeutic strategies.
Career Highlights
Throughout her career, Matikainien has worked with prominent organizations, including Orion Corporation and the Ludwig Institute for Cancer Research Limited. Her work has been instrumental in pushing the boundaries of cancer research and treatment.
Collaborations
Matikainien has collaborated with esteemed colleagues such as Karai Alitalo and Olga Aprelikova, contributing to a rich exchange of ideas and advancements in her field.
Conclusion
Marja-Terttu Matikainien's innovative work in antibody research exemplifies her commitment to advancing medical science. Her contributions continue to impact the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile